Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Tang

Showing results (461-470 of 515) with videos related to

Pageof 52
Sort By:
EMBO Molecular Medicine|July 14, 2020
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signalingShi-Bing Li, Yan-Yan Liu, Li Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.
Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNALi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Journal of the National Cancer Institute|April 19, 2024
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinomaDa-Feng Lin, Hai-Lin Li, Ting Liu, et al.
Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Clinical Chemistry|March 24, 2022
Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening ProgramsGeng Hang Chen, Zhiwei Liu, Kelly J Yu, et al.
Oncotarget|June 16, 2016
High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinomaYan-Yan Liu, Shao-Jun Lin, Yuan-Yuan Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2023
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patientsYu-Jing Liang, Qiu-Yan Chen, Jing-Xiao Xu, et al.
Plos One|December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Bin Qi, Xiang Guo, et al.
Pageof 52

Showing results (461-470 of 515) with videos related to

Sort By:
Pageof 52
EMBO Molecular Medicine|July 14, 2020
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signalingShi-Bing Li, Yan-Yan Liu, Li Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.
Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNALi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Journal of the National Cancer Institute|April 19, 2024
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinomaDa-Feng Lin, Hai-Lin Li, Ting Liu, et al.
Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Clinical Chemistry|March 24, 2022
Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening ProgramsGeng Hang Chen, Zhiwei Liu, Kelly J Yu, et al.
Oncotarget|June 16, 2016
High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinomaYan-Yan Liu, Shao-Jun Lin, Yuan-Yuan Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2023
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patientsYu-Jing Liang, Qiu-Yan Chen, Jing-Xiao Xu, et al.
Plos One|December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Bin Qi, Xiang Guo, et al.
Pageof 52